Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection

Date
2020
Author
Kulcsar, Andrea
Maritsi, Despoina
KASAPÇOPUR, Özgür
Rodrigues, Mariana
Smerla, Roubini
Rigante, Donato
Makay, Balahan
Atsali, Erato
Wulffraat, Nico
Toplak, Natasa
Uziel, Yosef
Moshe, Veronica
Onozo, Beata
Trobert-Sipos, Diana
Akikusa, Jonathan D.
Pileggi, Gecilmara Salviato
Metadata
Show full item record
Abstract
Purpose: To collect retrospective data of patients with Juvenile Idiopathic Arthritis (JIA) and other rheumatic diseases who received live attenuated booster measles-mumps-rubella (MMR) or measles-mumps-rubellavaricella (MMR/V) during treatment with immunosuppressive therapy.
URI
http://hdl.handle.net/20.500.12627/113376
https://doi.org/10.1016/j.vaccine.2020.01.037
Collections